Effect of Atractylodes macrocephala rhizoma on isoproterenol‑induced ventricular remodeling in rats

Xiao-Hua Cui1, Hui-Lin Wang1, Rong Wu1

  • 1Department of Pharmacology, School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, P.R. China.

Insights

Atractylodis macrocephalae rhizoma (AMR) may reverse ventricular remodeling after myocardial infarction by reducing oxidative stress and inhibiting the rennin-angiotensin-aldosterone system (RAAS). This study investigated AMR

Area of Science:

  • Cardiology
  • Pharmacology
  • Integrative Medicine

Background:

  • Myocardial infarction (MI) is a leading cause of ventricular remodeling (VR).
  • Ventricular remodeling significantly impacts cardiac function and patient prognosis.
  • Identifying therapeutic agents to mitigate VR is crucial for cardiovascular health.

Purpose of the Study:

  • To investigate the effects of Atractylodis macrocephalae rhizoma (AMR) on isoproterenol (ISO)-induced ventricular remodeling in a rat model.
  • To elucidate the underlying mechanisms by which AMR may exert protective effects against cardiac damage.

Main Methods:

  • Male Sprague Dawley rats were divided into normal control, ISO-induced, and AMR treatment groups.
  • Isoproterenol (85 mg/kg/day) was administered subcutaneously for two consecutive days to induce myocardial injury.
  • AMR treatment effects were assessed by evaluating hemodynamic parameters, myocardial pathology, cardiac hypertrophy, fibrosis, oxidative stress, and RAAS activation.

Main Results:

  • AMR administration normalized hemodynamic parameters compared to the ISO-induced group.
  • AMR significantly attenuated myocardial pathological damage, cardiac hypertrophy, and myocardial fibrosis.
  • AMR inhibited oxidative stress and suppressed the activation of the rennin-angiotensin-aldosterone system (RAAS).

Conclusions:

  • Atractylodis macrocephalae rhizoma (AMR) demonstrates potential in reversing ventricular remodeling induced by isoproterenol.
  • AMR's cardioprotective effects are likely mediated through its antioxidant properties and inhibition of RAAS activation.
  • AMR may serve as a therapeutic strategy for managing post-myocardial infarction ventricular remodeling.